SPOTLIGHT -
Operational Processes and Challenges
Mark Robson, MD; John Henson, MD; Ashley Ross, MD, PhD; and Dana Farengo Clark, MS, LCGC, discuss operational processes and techniques for counseling patients about germline testing.
Read More
Role of ctDNA in Germline Testing
Mark Robson, MD; John Henson, MD; Ashley Ross, MD, PhD; and Dana Farengo Clark, MS, LCGC, discuss the evolving role of circulating tumor DNA (ctDNA) in germline testing.
Identification of Patients for Germline Testing
The panel of experts provide insight on how they identify patients for germline testing.
Experience with Interpreting Somatic Reports
A panel of experts share their experiences with interpreting information on somatic reports and provide recommendations for verifying results.
Tumor-Normal Matched Sequencing and Platforms Utilized for Tumor Profiling
Mark Robson, MD, reviews data from a recent abstract on incidental germline findings detected by tumor-normal matched sequencing and the panelists share which platforms they utilize for tumor profiling.
Defining Germline Sequencing and Incidental Germline Findings
Mark Robson, MD, and a panel of experts discuss key terminology and definitions related to tumor and germline sequencing.
Dr Hamilton on the Efficacy and Safety of Abemaciclib Plus ET in Elderly Patients With HR+/HER2- Breast Cancer
Acalabrutinib and Zanubrutinib Produce Similar PFS in a Matching-Adjusted Indirect Comparison in R/R CLL
Nivolumab Plus Relatlimab Demonstrates Consistent Benefit for Patients with Advanced Melanoma
Dr Rini on Sustained Survival Outcomes After Completion of Pembrolizumab and Axitinib in ccRCC
